임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
30건 표시
- 1상모집 중· Diabetes Mellitus, Type 2A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 1상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 1상모집 중· Small Cell Lung CancerStudy of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
리드: 암젠
- 1상모집 중· Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
리드: 암젠
- 1상모집 중단 (진행 중)· Healthy ParticipantsComparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
리드: 암젠
- 1상모집 중단 (진행 중)· OverweightEffect of Maridebart Cafraglutide on the Heart's Electrical Activity
리드: 암젠
- 1상모집 중· Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
리드: 암젠
- 1상모집 중· Extensive Stage Small Cell Lung CancerA Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
리드: 암젠
- 1상모집 중단 (진행 중)· Type 2 Diabetes MellitusA Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 1상모집 중· KRAS Altered Advanced or Metastatic Solid TumorsAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
리드: 암젠
- 1상모집 중· Extensive Stage Small Cell Lung CancerSubcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
리드: 암젠
- 1상모집 중단 (진행 중)· Prostate CancerEvaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
리드: 암젠
- 1상모집 중· Cardiometabolic DiseaseSingle and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
리드: 암젠
- 1상모집 중단 (진행 중)· Advanced Gastrointestinal, Biliary Tract, and Pancreatic CancersA Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
리드: 암젠
- 1상모집 중단 (진행 중)· Advanced Solid TumorsA Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
리드: 암젠
- 1상모집 중단 (진행 중)· Extensive Stage Small Cell Lung CancerFirst-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
리드: 암젠
- 1상모집 중· Prostate CancerStudy of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 암젠
- 1상모집 중단 (진행 중)· Advanced Solid TumorsSotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
리드: 암젠
- 1상모집 중단 (진행 중)· Small Cell Lung CarcinomaStudy Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
리드: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.